Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia.

Viruses · 2025 · PMC12197668 · PMID 40573334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

Conclusions This study demonstrates the effectiveness of ledipasvir/sofosbuvir in achieving high rates of initial viral suppression and highlights an encouraging trend of lower viral relapse rates after long-term follow-up.

also in 154 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.